Search research articles
Contact Us
Filters
Showing results (101-110 of 142) with videos related to
Page
of 15
Sort By:
Circulation
|
August 10, 1999
PREDICT: A simple risk score for clinical severity and long-term prognosis after hospitalization for acute myocardial infarction or unstable angina: the Minnesota heart survey
D R Jacobs, C Kroenke, R Crow, et al.
Acta Medica Scandinavica. Supplementum
|
January 1, 1986
Population strategies to enhance physical activity: the Minnesota Heart Health Program
R Crow, H Blackburn, D Jacobs, et al.
Transfusion
|
April 24, 2010
Transfusion of antibody-opsonized red blood cells results in a shift in the immune response from the red blood cell to the antibody in a murine model
Davor Brinc, Hoang Le-Tien, Andrew R Crow, et al.
Circulation
|
April 1, 1992
Intermittent ST depression and mortality after myocardial infarction
W Ruberman, R Crow, C R Rosenberg, et al.
The American Journal of Cardiology
|
January 15, 1989
Electrocardiographic left ventricular hypertrophy and effects of antihypertensive drug therapy in hypertensive participants in the Multiple Risk Factor Intervention Trial
S MacMahon, G Collins, P Rautaharju, et al.
The Journal of Antimicrobial Chemotherapy
|
February 1, 1997
Methicillin susceptibility testing of staphylococci by Etest and comparison with agar dilution and mecA detection
T M Weller, D W Crook, M R Crow, et al.
Journal of Electrocardiology
|
January 1, 1993
Improved ECG models for estimation of left ventricular hypertrophy progression and regression incidence by redefinition of the criteria for a significant change in left ventricular hypertrophy status. The MRFIT Research Group. Multiple Risk Factor Intervention Trial
S H Zhou, P M Rautaharju, R Prineas, et al.
Circulation
|
March 1, 1987
Unrecognized myocardial infarction: experience in the Multiple Risk Factor Intervention Trial (MRFIT)
R H Grimm, S Tillinghast, K Daniels, et al.
Blood
|
March 22, 2003
IVIg-mediated amelioration of murine ITP via FcgammaRIIB is independent of SHIP1, SHP-1, and Btk activity
Andrew R Crow, Seng Song, John Freedman, et al.
Antimicrobial Agents and Chemotherapy
|
May 18, 2011
SugE, a new member of the SMR family of transporters, contributes to antimicrobial resistance in Enterobacter cloacae
Gui-Xin He, Chu Zhang, Robert R Crow, et al.
Page
of 15
Search research articles
Search
Showing results (101-110 of 142) with videos related to
Sort By:
Page
of 15
Circulation
|
August 10, 1999
PREDICT: A simple risk score for clinical severity and long-term prognosis after hospitalization for acute myocardial infarction or unstable angina: the Minnesota heart survey
D R Jacobs, C Kroenke, R Crow, et al.
Acta Medica Scandinavica. Supplementum
|
January 1, 1986
Population strategies to enhance physical activity: the Minnesota Heart Health Program
R Crow, H Blackburn, D Jacobs, et al.
Transfusion
|
April 24, 2010
Transfusion of antibody-opsonized red blood cells results in a shift in the immune response from the red blood cell to the antibody in a murine model
Davor Brinc, Hoang Le-Tien, Andrew R Crow, et al.
Circulation
|
April 1, 1992
Intermittent ST depression and mortality after myocardial infarction
W Ruberman, R Crow, C R Rosenberg, et al.
The American Journal of Cardiology
|
January 15, 1989
Electrocardiographic left ventricular hypertrophy and effects of antihypertensive drug therapy in hypertensive participants in the Multiple Risk Factor Intervention Trial
S MacMahon, G Collins, P Rautaharju, et al.
The Journal of Antimicrobial Chemotherapy
|
February 1, 1997
Methicillin susceptibility testing of staphylococci by Etest and comparison with agar dilution and mecA detection
T M Weller, D W Crook, M R Crow, et al.
Journal of Electrocardiology
|
January 1, 1993
Improved ECG models for estimation of left ventricular hypertrophy progression and regression incidence by redefinition of the criteria for a significant change in left ventricular hypertrophy status. The MRFIT Research Group. Multiple Risk Factor Intervention Trial
S H Zhou, P M Rautaharju, R Prineas, et al.
Circulation
|
March 1, 1987
Unrecognized myocardial infarction: experience in the Multiple Risk Factor Intervention Trial (MRFIT)
R H Grimm, S Tillinghast, K Daniels, et al.
Blood
|
March 22, 2003
IVIg-mediated amelioration of murine ITP via FcgammaRIIB is independent of SHIP1, SHP-1, and Btk activity
Andrew R Crow, Seng Song, John Freedman, et al.
Antimicrobial Agents and Chemotherapy
|
May 18, 2011
SugE, a new member of the SMR family of transporters, contributes to antimicrobial resistance in Enterobacter cloacae
Gui-Xin He, Chu Zhang, Robert R Crow, et al.
Page
of 15